{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:24Z","timestamp":1790681304231,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.actatropica.2014.09.020","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T19:10:46Z","timestamp":1412881846000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"PA","title":["Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii"],"prefix":"10.1016","volume":"141","author":[{"given":"Lobna A.","family":"El-Zawawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen F.","family":"Mossallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa S.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.actatropica.2014.09.020_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1742-7843.2009.00455.x","article-title":"Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones","volume":"105","author":"Allmyr","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.actatropica.2014.09.020_bib0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","article-title":"Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii","volume":"35","author":"Araujo","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.actatropica.2014.09.020_bib0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.36.2.326","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii","volume":"36","author":"Araujo","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0020","series-title":"Liposomes in Biological Systems","first-page":"1","article-title":"Development of the liposome concept","author":"Bangham","year":"1980"},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4269\/ajtmh.2003.68.334","article-title":"Growth inhibitory effect of triclosan on equine and bovine Babesia parasites","volume":"68","author":"Bork","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.actatropica.2014.09.020_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijpara.2006.12.010","article-title":"Delayed parasite elimination in human infections treated with clindamycin parallels \u2018delayed death\u2019 of Plasmodium falciparum in vitro","volume":"37","author":"Burkhardt","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0035","series-title":"Thick Sections: Technique and Applications. Diagnostic Electron Microscopy","first-page":"141","author":"Burns","year":"1978"},{"issue":"6","key":"10.1016\/j.actatropica.2014.09.020_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0020-7519(00)00053-9","article-title":"Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis","volume":"30","author":"Cauchetier","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"9","key":"10.1016\/j.actatropica.2014.09.020_bib0045","doi-asserted-by":"crossref","first-page":"e25259","DOI":"10.1371\/journal.pone.0025259","article-title":"MIF participates in Toxoplasma gondii-induced pathology following oral infection","volume":"6","author":"Cavalcanti","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.actatropica.2014.09.020_bib0050","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.05183-11","article-title":"Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis","volume":"56","author":"Chew","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exppara.2011.10.004","article-title":"Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts","volume":"130","author":"Chew","year":"2012","journal-title":"Exp. Parasitol."},{"issue":"9","key":"10.1016\/j.actatropica.2014.09.020_bib0060","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/339551","article-title":"Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 Study","volume":"34","author":"Chirgwin","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.actatropica.2014.09.020_bib0065","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.placenta.2009.08.002","article-title":"Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae)","volume":"30","author":"Costa","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.actatropica.2014.09.020_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-59745-210-6_9","article-title":"Drug delivery in cancer using liposomes","volume":"437","author":"Dass","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.actatropica.2014.09.020_bib0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkf251","article-title":"Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii","volume":"50","author":"Djurkovi\u0107-Djakovi\u0107","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.exppara.2012.05.006","article-title":"Kinetics of parasite burdens in blood and tissues during murine toxoplasmosis","volume":"131","author":"Djurkovi\u0107-Djakovi\u0107","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin. Microbiol."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","article-title":"Congenital toxoplasmosis: priorities for further health promotion action","volume":"122","author":"Elsheikha","year":"2008","journal-title":"Public Health"},{"key":"10.1016\/j.actatropica.2014.09.020_bib0095","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jac\/dkg258","article-title":"Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads","volume":"51","author":"Faber","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425247.5.1.25","article-title":"Liposomal nanomedicines","volume":"5","author":"Fenske","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.actatropica.2014.09.020_bib0105","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/AAC.39.7.1530","article-title":"In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii","volume":"39","author":"Fichera","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6658","key":"10.1016\/j.actatropica.2014.09.020_bib0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/37132","article-title":"A plastid organelle as a drug target in apicomplexan parasites","volume":"390","author":"Fichera","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2014.09.020_bib0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0149-2918(96)80059-2","article-title":"Treatment regimens for patients with toxoplasmic encephalitis","volume":"18","author":"Fung","year":"1996","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138945007779315579","article-title":"Fatty acid biosynthesis as a drug target in apicomplexan parasites","volume":"8","author":"Goodman","year":"2007","journal-title":"Curr. Drug Targets"},{"issue":"5","key":"10.1016\/j.actatropica.2014.09.020_bib0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00249-003-0378-8","article-title":"Location and orientation of triclosan in phospholipid model membranes","volume":"33","author":"Guill\u00e9n","year":"2004","journal-title":"Eur. Biophys. J."},{"issue":"16","key":"10.1016\/j.actatropica.2014.09.020_bib0135","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1074\/jbc.274.16.11110","article-title":"Mechanism of triclosan inhibition of bacterial fatty acid synthesis","volume":"274","author":"Heath","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0022034511425046","article-title":"Triclosan antagonizes fluconazole activity against Candida albicans","volume":"91","author":"Higgins","year":"2012","journal-title":"J. Dent. Res."},{"issue":"2","key":"10.1016\/j.actatropica.2014.09.020_bib0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","article-title":"Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS","volume":"22","author":"Katlama","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.actatropica.2014.09.020_bib0150","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/molecules17089207","article-title":"Real time anti-Toxoplasma gondii activity of an active fraction of Eurycoma longifolia root studied by in situ scanning and transmission electron microscopy","volume":"17","author":"Kavitha","year":"2012","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/CMR.8.3.427","article-title":"Human antiprotozoal therapy: past, present, and future","volume":"8","author":"Khaw","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nbt1184-979","article-title":"Dehydration\u2013rehydration vesicles: a simple method for high yield drug entrapment in liposomes","volume":"2","author":"Kirby","year":"1984","journal-title":"Biotechnology"},{"issue":"6","key":"10.1016\/j.actatropica.2014.09.020_bib0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"35","key":"10.1016\/j.actatropica.2014.09.020_bib0170","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1073\/pnas.1208775109","article-title":"Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections","volume":"109","author":"Lai","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.actatropica.2014.09.020_bib0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-7799(98)01220-7","article-title":"Novel applications of liposomes","volume":"16","author":"Lasic","year":"1998","journal-title":"Trends Biotechnol."},{"issue":"14","key":"10.1016\/j.actatropica.2014.09.020_bib0180","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1017\/S0031182007003319","article-title":"Type I and type II fatty acid biosynthesis in Eimeria tenella: enoyl reductase activity and structure","volume":"134","author":"Lu","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2014.09.020_bib0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS (AIDS commentary)","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0190","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/02652040400015411","article-title":"Formulation and characterization of triclosan sub-micron emulsions and nanocapsules","volume":"21","author":"Maestrelli","year":"2004","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0200","first-page":"419","article-title":"The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations","volume":"238","author":"Matuschka","year":"1977","journal-title":"Zentralbl. Bakteriol. Orig. A"},{"issue":"8","key":"10.1016\/j.actatropica.2014.09.020_bib0205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0966-842X(99)01547-4","article-title":"Apicomplexan plastids as drug targets","volume":"7","author":"McFadden","year":"1999","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0020-7519(01)00111-4","article-title":"Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I","volume":"31","author":"McLeod","year":"2001","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1105\/tpc.12.3.405","article-title":"Deficiency in fatty acid synthase leads to premature cell death and dramatic alterations in plant morphology","volume":"12","author":"Mou","year":"2000","journal-title":"Plant Cell"},{"issue":"11","key":"10.1016\/j.actatropica.2014.09.020_bib0220","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/EC.00262-07","article-title":"Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii","volume":"6","author":"Nagamune","year":"2007","journal-title":"Eukaryot. Cell"},{"issue":"4","key":"10.1016\/j.actatropica.2014.09.020_bib0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1476-5381.1983.tb10537.x","article-title":"Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice","volume":"9","author":"Nguyen","year":"1983","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.actatropica.2014.09.020_bib0230","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/EC.3.4.855-861.2004","article-title":"Multiple triclosan targets in Trypanosoma brucei","volume":"3","author":"Paul","year":"2004","journal-title":"Eukaryot. Cell"},{"issue":"2","key":"10.1016\/j.actatropica.2014.09.020_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/toxsci\/kfp271","article-title":"Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in young long-evans rats","volume":"113","author":"Paul","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.actatropica.2014.09.020_bib0240","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2217\/fmb.09.89","article-title":"Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients","volume":"4","author":"Pereira-Chioccola","year":"2009","journal-title":"Future Microbiol."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0245","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.M112000200","article-title":"Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase","volume":"277","author":"Perozzo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrmicro843","article-title":"Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast","volume":"2","author":"Ralph","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0255","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/AAC.00808-06","article-title":"Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum","volume":"51","author":"Ramya","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.actatropica.2014.09.020_bib0260","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/10408441003667514","article-title":"Triclosan: a critical review of the experimental data and development of margins of safety for consumer products","volume":"40","author":"Rodricks","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"issue":"March (3)","key":"10.1016\/j.actatropica.2014.09.020_bib0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543776.2012.668886","article-title":"New antibacterials for the treatment of toxoplasmosis; a patent review","volume":"22","author":"Rodriguez","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"issue":"24","key":"10.1016\/j.actatropica.2014.09.020_bib0270","doi-asserted-by":"crossref","first-page":"14281","DOI":"10.1073\/pnas.2436169100","article-title":"Delivery of antimicrobials into parasites","volume":"100","author":"Samuel","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.actatropica.2014.09.020_bib0275","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.45.6.1771-1779.2001","article-title":"Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis","volume":"45","author":"Sch\u00f6ler","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.actatropica.2014.09.020_bib0280","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/AAC.47.12.3859-3866.2003","article-title":"Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge","volume":"47","author":"Sharma","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1051\/parasite\/1998053223","article-title":"Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis","volume":"5","author":"Sordet","year":"1998","journal-title":"Parasite"},{"key":"10.1016\/j.actatropica.2014.09.020_bib0290","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1574-6976.2011.00305.x","article-title":"Mechanisms of Toxoplasma gondii persistence and latency","volume":"36","author":"Sullivan","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2014.09.020_bib0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","article-title":"Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum","volume":"7","author":"Surolia","year":"2001","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0300","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.peptides.2011.07.027","article-title":"Parasiticidal activity of Haemaphysalis longicornis longicin P4 peptide against Toxoplasma gondii","volume":"34","author":"Tanaka","year":"2012","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.actatropica.2014.09.020_bib0305","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5732\/cjc.010.10075","article-title":"Recent progress in nanotechnology for cancer therapy","volume":"29","author":"Tang","year":"2010","journal-title":"Chin. J. Cancer."},{"issue":"3","key":"10.1016\/j.actatropica.2014.09.020_bib0310","first-page":"166","article-title":"Evaluation of suitable solvents for testing the anti-proliferative activity of triclosan \u2013 a hydrophobic drug in cell culture","volume":"47","author":"Vandhana","year":"2010","journal-title":"Indian J. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/abbi.2001.2356","article-title":"Membranotropic effects of the antibacterial agent triclosan","volume":"390","author":"Villala\u00edn","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.actatropica.2014.09.020_bib0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AAC.47.1.297-301.2003","article-title":"A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum","volume":"47","author":"Waller","year":"2003","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1400312X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1400312X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T02:05:08Z","timestamp":1565921108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X1400312X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":62,"alternative-id":["S0001706X1400312X"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2014.09.020","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2014.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}